Thermo Fisher agrees to sell microbiology business to Astorg in $1bn deal [Yahoo! Finance]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
ongoing pivot away from in vitro diagnostics (IVD) towards bolstering its biopharma presence. Thermo Fisher expects the deal to close in H2 2026 and intends to provide details on its impact to the company's 2026 outlook during a Q2 earnings call. “The transaction reflects our active management of the company and provides additional capital we can deploy to create shareholder value,” said Thermo Fisher CEO Marc N. Casper. Astorg said it would partner closely with management to further scale the business, aiming to accelerate growth and enhance operational performance. Thermo Fisher's microbiology business generated $645m in revenue in 2025 and is part of the company's broader speciality diagnostics business segment. The business has approximately 2,400 employees, alongside 13 manufacturing and R&D sites around the world. Despite this healthy revenue generation, Thermo Fisher's planned divestment of the business reflects its pivot out of the IVD space, Dr Andrew S Thompson, di
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- 1 Profitable Stock with Impressive Fundamentals and 2 Facing Headwinds [Yahoo! Finance]Yahoo! Finance
- Global AAV Vector Manufacturing Market Gearing Up for Outstanding Expansion at a CAGR of ~22% by 2034 | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Scientific to Host Investor DayBusiness Wire
- Devyser Diagnostics AB (STU:OL0) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher selling microbiology business to Astorg for $1.08B [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 4/23/26 - Beat
TMO
Sec Filings
- 4/27/26 - Form 144
- 4/23/26 - Form 8-K
- 4/7/26 - Form ARS
- TMO's page on the SEC website